A new ultra-compact genetic tool called TIGRa was developed to activate protective genes within the human body, promising to treat and prevent diseases from within the organism. The technology allows precise adjustment of gene expression, increasing beneficial genes and reducing harmful ones.
The molecular tools currently used, such as the CRISPR system, cannot act directly on the body's cells. This limitation represented a significant obstacle to the development of in vivo genetic therapies.
The ability to modify genes precisely within the human organism has enormous medical potential. The technology is expected to be applied in both the treatment and prevention of various diseases.
TIGRa represents an advancement by overcoming the limitations of existing tools, offering a new approach to genetic manipulation that can operate directly on human body cells.
